Anzeige
Mehr »
Login
Donnerstag, 30.01.2025 Börsentäglich über 12.000 News von 684 internationalen Medien
Absoluter Geheimtipp: Vergessen Sie Gold, Silber und Uran!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
790 Leser
Artikel bewerten:
(2)

Atos International: Atos enters into exclusive negotiations for the sale of EcoAct

Finanznachrichten News

Press Release

Atos entersinto exclusive negotiationsfor the sale of EcoAct

  • Major progress ontransformation plan:
    100% of Atos'divestment program secured
  • Strategic partnership with Schneider Electric on decarbonization

Paris, France - July3, 2023- Atos Group, a global leader in digital transformation, today announces that it has entered into exclusive negotiations with Schneider Electric for the sale of 100% of EcoAct SAS and its subsidiaries ("EcoAct"). With this potential transaction, Atos would secure its divestment program of non-core assets while engaging in a strategic partnership with Schneider Electric on decarbonization.

EcoAct is an international leader in climate consulting and NetZero solutions offering a unique portfolio of services which covers the entire Net Zero transition value chain, from planning and forecasting to carbon offsetting. The company generated revenues of approximately €70m in FY22 and currently employs close to 400 people.

The proposed transaction does not include Atos' digital Net Zero Transformation practice (part of Eviden business), dedicated to supporting its customers in all industries to catalyze their decarbonization goals, which will be kept within the Atos Group. Atos would also cooperate closely with Schneider Electric combining Technology and Sustainability expertise to build products and solutions that enhance its customers' paths to NetZero.
Atos remains highly committed to its own sustainability engagements which are set to achieve net zero carbon emissions by 2039.

This proposed transaction, in addition to the ongoing divestments already engaged, would allow Atos to complete its divestment program ahead of the schedule announced at the Group's Capital Markets Day on June 14, 2022.

"We are very pleased with this proposed transaction,after which we would have secured more than100% ofour divestment program and delivered on our commitment.Our transformation plan has already showed encouraging performance results, and we have further reinforced our clients' confidence in our ability to accompany them in their digital challenges" said Diane Galbe, Senior Executive Vice President, Atos "Digitization and decarbonizationare key for all businesses today.Thanks to this future partnershipwith Schneider Electric we look forward to developing leading edge offers to accelerate customers'journeys to NetZero."

Steve Wilhite,President, Sustainability Business atSchneider Electric said "Demand for sustainable goods and services is rapidly increasing as businesses navigate the challenges posed by climate change, the energy crisis, and investor and regulatory pressures. The solutions to these challenges are complex to navigate. By combining forces with EcoAct, we would expand our team of world-class sustainability consultants and our ability to deliver strategic value to our clients,accelerating the transition to the carbon-free energy future."

Stuart Lemmon, Global Head of EcoAct, said "I am excited for EcoAct to potentially joinSchneider Electric and to continue to grow our ability to lead clients through challenges at the heart of the energy and resource transition. I believe this transaction could provide fantastic opportunities to our talented and passionate 'EcoActors' and look forward to the promising future ahead."

The potential transaction remains subject to the information and consultation of the relevant employee representative bodies of Atos and Schneider Electric, to the agreement and signing of the definitive documentation and to other customary regulatory approvals. The potential transaction is expected to be closed in H2 2023.

***

About Atos

Atos is a global leader in digital transformation with 110,000 employees and annual revenue of c. € 11 billion. European number one in cybersecurity, cloud and high-performance computing, the Group provides tailored end-to-end solutions for all industries in 69 countries. A pioneer in decarbonization services and products, Atos is committed to a secure and decarbonized digital for its clients. Atos is a SE (Societas Europaea) and listed on Euronext Paris.

The purpose of Atosis to help design the future of the information space. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world, the Group enables its customers and employees, and members of societies at large to live, work and develop sustainably, in a safe and secure information space.

Contacts

Investor relations: Thomas Guillois | thomas.guillois@atos.net| +33 (0)6 21 34 36 62

Media: Martin Bovo | martin.bovo@atos.net | +33 (0)6 14 46 79 94

Attachment

  • PR - Atos enters into exclusive negotiations for the sale of EcoAct - final (https://ml-eu.globenewswire.com/Resource/Download/823ba607-e38a-4719-b3a3-7942e748fb8c)

© 2023 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.